GB1841 is an orally active and selective galectin inhibitor with human galectin-1 K d of 0.027 μM, human galectin-3 K d of 0.14 μM, mouse galectin-1 K d of 0.034 μM and mouse galectin-3 K d of 1.170 μM. GB1841 can be used for the research of lung cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Galectin
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。